Cemat A/S
Nasdaq Copenhagen
Nikolaj Plads 6
DK-1067 Copenhagen K
Copenhagen, 24 March 2021
ANNOUNCEMENT no 9/2021
Managers’ transactions
Pursuant to Article 19 of the market abuse regulation Cemat A/S hereby announces the following information received 23 March 2021.
| Name: | Joanna Lucyna Iwanowska-Nielsen |
| Reason for filing: | Insider |
| Company name: | Cemat A/S |
| Identification code and name: | ISIN DK0010271584 |
| Transaction type: | Purchase |
| Date: | 19 March 2021 |
| Market: | Nasdaq Copenhagen |
| Number of traded shares: | 75,000 |
| Price: | 0.50 |
Cemat A/S
Jaroslaw Pawel Lipinski
CEO
This announcement has been prepared in a Danish-language and an English-language
version. In case of doubt, the Danish version prevails.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Biotalys NV18.9.2025 07:00:00 CEST | Press release
Biotalys Reports Half-Year 2025 Financial Results and Business Highlights
F. Hoffmann-La Roche Ltd18.9.2025 07:00:00 CEST | Press release
Roche enters into a definitive merger agreement to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASH
Ascom Holding AG18.9.2025 06:30:00 CEST | Press release
Michael Reitermann takes over the operational leadership of the Ascom Group as Delegate of the Board of Directors and interim CEO
Novo Nordisk A/S17.9.2025 23:05:02 CEST | Press release
Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study
Biogen Inc.17.9.2025 22:30:05 CEST | Press release
Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom